Holen Sie sich die Stockscreener-App
2.85
4.04%
-0.12
Schlusskurs vom Vortag:
$2.97
Offen:
$2.82
24-Stunden-Volumen:
8,738
Relative Volume:
0.56
Marktkapitalisierung:
$103.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.36M
KGV:
-1.7378
EPS:
-1.64
Netto-Cashflow:
$-42.09M
1W Leistung:
+14.00%
1M Leistung:
+10.89%
6M Leistung:
+41.09%
1J Leistung:
+18.75%
1-Tages-Spanne:
$2.762
$2.875
1-Wochen-Bereich:
$2.40
$3.14
52-Wochen-Spanne:
$0.8981
$3.14
Armata Pharmaceuticals Inc Stock (ARMP) Company Profile
Firmenname
Armata Pharmaceuticals Inc
Sektor
Branche
Telefon
310-655-2928
Adresse
4503 Glencoe Avenue, Marina del Rey, CA
Vergleichen Sie ARMP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARMP
Armata Pharmaceuticals Inc
|
2.85 | 107.60M | 0 | -41.36M | -42.09M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-06-19 | Eingeleitet | Ladenburg Thalmann | Buy |
Armata Pharmaceuticals Inc Aktie (ARMP) Neueste Nachrichten
Armata Pharmaceuticals Inc. stock chart pattern explained2025 Price Action Summary & Safe Entry Trade Reports - Newser
Is Armata Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Detecting price anomalies in Armata Pharmaceuticals Inc. with AI2025 Market Sentiment & AI Forecast Swing Trade Picks - Newser
Volume spikes in Armata Pharmaceuticals Inc. stock – what they meanWeekly Trade Report & Fast Entry Momentum Trade Alerts - Newser
Strategies to average down on Armata Pharmaceuticals Inc.Quarterly Risk Review & Free Weekly Chart Analysis and Trade Guides - Newser
What are analysts’ price targets for Armata Pharmaceuticals Inc.2025 Market Outlook & AI Driven Stock Reports - خودرو بانک
Will Armata Pharmaceuticals Inc. benefit from green energy policiesJuly 2025 Analyst Calls & Safe Entry Trade Signal Reports - خودرو بانک
How to recover losses in Armata Pharmaceuticals Inc. stockMarket Growth Summary & Verified Entry Point Detection - Newser
What is Armata Pharmaceuticals Inc.’s valuation compared to sector2025 Technical Overview & Expert Approved Trade Ideas - خودرو بانک
What is Armata Pharmaceuticals Inc. s revenue forecastQuarterly Profit Summary & Fast Entry High Yield Stock Tips - خودرو بانک
Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Eastern Progress
Inflation Data: Is Armata Pharmaceuticals Inc. impacted by rising ratesJuly 2025 Breakouts & Fast Moving Stock Trade Plans - خودرو بانک
How cyclical is Armata Pharmaceuticals Inc.’s revenue streamJuly 2025 Pullbacks & Reliable Price Breakout Alerts - خودرو بانک
Can Armata Pharmaceuticals Inc. recover in the next quarterTrade Performance Summary & Precise Swing Trade Alerts - Newser
Chart based exit strategy for Armata Pharmaceuticals Inc.Trade Risk Report & Low Risk High Reward Ideas - Newser
Armata Pharmaceuticals shares rise 2% after-hours as CEO to present at H.C. Wainwright conference. - AInvest
Bacteriophage Therapeutics Pioneer Armata Pharmaceuticals to Showcase Pipeline at Major Investment Conference - Stock Titan
Combining price and volume data for Armata Pharmaceuticals Inc.Weekly Stock Summary & Verified Momentum Stock Alerts - Newser
Multi asset correlation models including Armata Pharmaceuticals Inc.Weekly Trade Recap & Breakout Confirmation Alerts - Newser
What recovery options are there for Armata Pharmaceuticals Inc.2025 Analyst Calls & Consistent Growth Equity Picks - Newser
What to expect from Armata Pharmaceuticals Inc. in the next 30 daysWeekly Trend Recap & High Conviction Buy Zone Picks - Newser
Analyzing net buyer seller activity in Armata Pharmaceuticals Inc.Trade Entry Report & Risk Managed Investment Strategies - Newser
Risk Hedge: Will Armata Pharmaceuticals Inc. benefit from green energy policiesFed Meeting & Free Long-Term Investment Growth Plans - خودرو بانک
Is Armata Pharmaceuticals Inc. a cyclical or defensive stockQuarterly Trade Report & Long-Term Capital Growth Ideas - خودرو بانک
Is Armata Pharmaceuticals Inc. showing signs of accumulationEntry Point & Long-Term Capital Growth Strategies - Newser
Armata Pharmaceuticals Inc. stock trend outlook and recovery pathEarnings Performance Report & Low Volatility Stock Recommendations - Newser
Investment Report: How does Armata Pharmaceuticals Inc. perform in inflationary periodsJuly 2025 Highlights & AI Powered Buy and Sell Recommendations - خودرو بانک
Technical Charts Suggest Momentum Shift in Armata Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Using Python tools to backtest Armata Pharmaceuticals Inc. strategies2025 Investor Takeaways & Consistent Growth Stock Picks - Newser
S P Trends: How liquid is Armata Pharmaceuticals Inc. stock2025 Retail Activity & Stepwise Swing Trade Plans - خودرو بانک
What’s the recovery path for long term holders of Armata Pharmaceuticals Inc.CEO Change & Smart Allocation Stock Reports - Newser
Will Armata Pharmaceuticals Inc. benefit from seasonalityTrade Analysis Report & Stepwise Swing Trade Plans - خودرو بانک
Armata Pharmaceuticals Inc. Approaches Psychological Resistance Level getLinesFromResByArray error: size == 0 - 강소기업뉴스
Will Armata Pharmaceuticals Inc. benefit from macro trendsWeekly Trend Recap & High Conviction Buy Zone Picks - Newser
Is Armata Pharmaceuticals Inc. still worth holding after the dipWeekly Stock Analysis & Daily Growth Stock Investment Tips - Newser
Can machine learning forecast Armata Pharmaceuticals Inc. recovery2025 Volatility Report & Weekly Hot Stock Watchlists - Newser
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year? - ca.finance.yahoo.com
Loss Report: What is the cash position of Armata Pharmaceuticals Inc.Market Sentiment Review & Risk Controlled Stock Pick Alerts - خودرو بانک
Finanzdaten der Armata Pharmaceuticals Inc-Aktie (ARMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):